3. Introduction
Definition:
Chemotherapy is the treatment of various diseases
caused by pathogenic organisms (bacteria, fungi,
viruses, protozoa, worms) with chemical substances,
which due to their selective toxicity, destroy or remove
pathogenic organisms without injuring the host. The
chemical substances used for this purpose are
chemotherapeutic agents.
Drugs use for treatment of cancer ( Antineoplastic
drugs) are also included in chemotherapy.
4. History of Chemotherapy
• The first drug used for cancer
chemotherapy did not start out as a
medicine.
Mustard gas was used as a chemical warfare
agent during World War I and was studied
further during World War II. During a military
operation in World War II, a group of people
were accidentally exposed to mustard gas and
were later found to have very low white blood
cell counts.
• Doctors reasoned that something that
damaged the rapidly growing white blood
cells might have a similar effect on cancer.
So, in the 1940s, several patients with
advanced lymphomas (cancers of certain
white blood cells) were given the drug by
vein, rather than by breathing the irritating
gas. Their improvement, although
temporary, was remarkable.
5. Discovered first cure for syphilis
Neoarsphenamine was widely used for treatment of syphilis
untill1945 when penicillin superseded it
6.
7. Antimicrobial Chemotherapy
1. Antibacterial Drugs: Antibiotics,
Sulphonamide, Quinolone, Anti TB Drugs,
Drugs for UTI etc
2. Antifungal Drugs
3. AntiViral Drugs
4. Anti Protozoal Drugs
5. Anthelmintics
8. Why chemotherapy is different from
other treatments
• Treatments like radiation and surgery are
considered local treatments. They act only in one
area of the body such as the breast, lung, or
prostate and usually target the cancer directly.
• Chemotherapy differs from surgery or radiation in
that it’s almost always used as a systemic
treatment.
• This means the drugs travel throughout the body
to reach cancer cells wherever they are.
9. Principle of Antimicrobial Therapy
•Site of infection
•Responsible organism
•Sensitivity of drug
Diagnosis
•Acute infection require chemotherapy while chronic infection
may not.
•The chronic abscess respond poorly, although chemotherapy
cover is essential if surgery is undertaken to avoid a flare-up of
infection
Decide
Chemotherapy
Is necessary
•Specificity (spectrum of activity, antimicrobial activity of drug)
•Pharmacokinetic factor
•Patient related factor
Select the drug
10. Principle of Antimicrobial Therapy
• Inadequate dose may develop resistance
• Intermediate dose may not cure disease
• Optimize dose should be use for therapy
Frequency and Duration
of Drug Administration
• Acute infection treated for 5-10days
• But for some infections such as TB, medication
continue to avoid relapse
Continue Therapy
• After therapy, symptoms and signs may
disappear before pathogen eradicated.
Test for Cure
11. Identification of infecting organisms
• Characterizing the organism is central to selection
of proper drug.
• A rapid assessment can be made by gram staining
which is useful in identifying presence of
microorganisms in body fluids that are normally
sterile ( Blood, Serum, CSF, Pleural Fluid, Peritoneal
Fluid and urine).
• However, it is necessary to culture infective
microorganism to arrive at conclusive diagnosis.
Thus it is imp to have sample prior to start
treatment
12. Empiric Therapy prior to identification
of micro organism
• Ideally, antimicrobial agent used to treat an
infection is select after the organism has been
identified and its drug susceptibility established.
However in critical cases, wait can be
dangerous. So immediate empiric therapy is
indicated.
• Broad spectrum therapy maybe indicated
initially started when organism is unknown or
polymicrobial infection is likely.
13. Determining antimicrobial
susceptibility of infective organism
• After organism is cultured, its susceptibility to
specific antibiotic serve as a guide in choosing
antimicrobial therapy.
• Some pathogens such as: Streptococcus pyogenes
and Neisseria meningitis, usually have predictable
susceptible pattern to certain antibiotics.
• In contrast, most gram negative bacilli, enterococci
and staphylococcus species often show
unpredictable susceptibility to various antibiotics.
Therefore require susceptibility testing to determine
appropriate therapy.
14. Bacteriostatic Vs Bacteriocidal
• Antimicrobial drugs are classified as either
bacteriostatic or bactericidal.
• Bacteriostatic drugs arrest the growth and replication
of bacteria at serum (or urine) levels achievable in
patient thus limiting spread of infection.
• Bactericidal drugs kill bacteria at drug serum levels
achievable in the patient. Because of their severe
action they are drug of choice in seriously ill patient.
• Example: Chloramphenicol is bacteriostatic against
gram –ive rods, and is bactericidal against other
organisms such S.pneumoniae.
15.
16. MIC & MBC
• MIC is minimum inhibitory concentration that is
lowest concentration of antibiotic that inhibit
bacterial growth. ( to provide effective therapy
antibiotic conc. in body tissue and fluids should
be greater than MIC)
• MBC is minimum bactericidal concentration
that kills the bacteria under investigation. The
minimum bactericidal concentration (MBC) is
lowest conc. of antimicrobial agent that kills
99.9%.
17. Effect of site of infection on therapy
• Adequate levels of antibiotic must reach site of
infection for invading micro organism.
• For this points of consideration are:
1. Lipid Solubility of drug
2. Molecular weight of drug
3. Protein binding of drug
18. Patient Factors
1. Immune System: Elimination of infecting organism depends upon
intact immune system. If weak then there will be problem
2. Renal Dysfunction: poor kidney function (10% or less of normal)
causes accumulation of antibiotics that would otherwise easily
eliminated. Dose adjustment needed!!!
3. Hepatic dysfunction: Antibiotics ( erythromycin and tetracycline)
must use with caution.
4. Poor Perfusion: decrease circulation to anatomic areas such as
lower limb, decrease the amount of antibiotic in that specific area.
5. Age: Renal/hepatic elimination processes are often poorly
developed in newborns, making neonate vulnerable to toxic
effects of chloramphenicol and sulfonamide. Young children
should not treated with tetracycline or qunilone which affect bone
growth.
19. 6. Pregnancy: Many antibiotics cross placenta.
Adverse effects are rare, except for tooth
dysplasia and inhibition of bone growth
encountered with tetracycline.
7. Lactation: Drug administered to a lactating
mother may enter the nursing infant via breast
milk. Although conc. Is low but the total dose to
infant maybe sufficient to produce determental
effects.
20. Safety of Agent
• Many antibiotics such as penicillin's, are among
the least toxic of all drugs because they
interfere with a site unique to the growth of
microorganisms. Other antimicrobial agents (for
example, chloramphenicol) are less
microorganism specific and are reserved for life
threatening infections because of the drug’s
potential for serious toxicity to patient.
21. Route Of Administration
• The oral route of administration is chosen for
infections that are mild and is favorable for
treatment on an outpatient basis.
• In patients using IV in start should switch to oral
agents should occur.
• However, some antibiotics such as vancomycin,
aminoglycosides and amphotericin B are so poorly
absorbed from GIT that adequate serum levels
cannot be obtained by oral administration.
22. Determinants of Rational Dosing
• Rational dosing depends upon drug
pharmacodynamics (the relationship of dug conc.
to antimicrobial effects) and pharmacokinetics
(ADME)
• Three imp properties that have a significant
influence on the frequency of dosing are:
1. Conc. Dependent killing (e.g Aminoglycoside)
2. Time Dependent killing (e.g Beta lactam)
3. Postantibiotic effect (e.g fluroquinolones)
23. Chemotherapeutic Spectra
1. Narrow Spectrum Antibiotics : chemotherapeutic
agents acting only on a single or a limited group of
micro organisms are said to have a narrow spectrum.
For example, isoniazid is active only against
mycobacteria.
2. Extended Spectrum Antibiotics: those antibiotics
which are effective against gram positive organisms
and also against a significant number of gram
negative bacteria. For example, ampicillin
3. Broad Spectrum Antibiotics: drugs such as
tetracycline and chloramphenicol affect a wide variety
of microbes.
24. Combination of Antimicrobial Drugs
• It is therapeutically advisable to treat patients
with a single agent that is most specific to the
infecting organism. This strategy reduces the
possibility of super infection, decrease
resistance, and minimize toxicity.
• For example: In tuberculosis combination of
therapy is used.
25. Advantages & Disadvantages of
combination
• Advantages: certain combination of antibiotics such as
beta lactam and aminoglycoside show synergism,
means combination is more effective than alone. (
multiple drugs are only given in special situation when
cause is unknown)
• Disadvantages: A no. of antibiotics act only when
micro organisms are multiplying. Thus, co
administration of an agent that causes bacteriostasis
plus second agent that is bactericidal may result in first
interfering with the action of second. ( for example:
bacteriostatic tetracycline drugs may interfere with
bactericidal effect of penicillin and cephalosporin)
26.
27. Drug Resistance
• Bacteria are said to be resistant to an antibiotic if the
maximal level of that antibiotic that can be tolerated by the
host does not halt their growth.
• Some organisms are inherently resistant to an antibiotic.
E.g Gram-ive organisms to vancomycin
• Other causes are:
1. Genetic alteration
Mutation of DNA
DNA transfer of drug resistance
2. Altered expression of proteins in drug resistant micro
organisms
Modification of target sites
Decrease accumulation
Enzymatic inactivation
28. Prophylactic antibiotics
• Antibiotics use for prevention rather than
treatment.
• Duration of prophylaxis should be closely
observed to prevent unnecessary antibiotic
exposure.
29. Complication of Antibiotic therapy
• Hypersensitivity ( Penicillin)
• Direct toxicity (aminoglycoside cause
ototoxicity)
• Super infections (Broad spectrum antibiotics
can suppress normal flora of the upper
respiratory, intestinal, and genitourinary leading
to overgrowth of opportunistic organisms
especially fungi which is difficult to treat)
32. Cell wall Synthesis inhibitors
• Some antimicrobial drugs selectively interfere with the
synthesis of bacterial cell wall- a structure that
mammalian cell do not posses.
• The cell wall is composed of polymer called
peptidoglycan that consists of glycan units joined to
each other by peptide cross links.
• To be maximally effective, inhibitors of cell wall
synthesis require actively proliferating micro
organisms, they have little or no effect on bacteria that
are not growing or dividing.
• The most important member of the group are beta
lactam antibiotics and vancomycin.
34. Penicillin
• First antibiotic, extracted from the mould, Pencillium notatum. The penicillins
are among the most widely effective and least toxic drugs known, but
increase resistance has limited their use.
• Member of this family differ from one and another in R substituent attached
to the 6-aminopencillianic acid residue. The nature of this side chain affects
the antimicrobial spectrum, stability to stomach acid, cross hypersensitivity
and susceptibility to bacterial degradative enzymes (ß lactamases).
• Benzylpenicillin ( penicillin G) was first natural penicillin available for clinical
use. Other natural penicillin are phenoxymethylpenicillin (penicillin V) and
phenethicillin.
• All penicillin contain Penicillin nucleus ( 6-aminopenicillinic acid) consisting of
a four membered beta lactam ring fused with a thiazolidine ring. The beta
lactam rings carries a secondary amino group ( R-NH) where acidic radical can
be attached to amino group at –R- thereby producing large number of semi
synthetic penicillins with different properties.
40. Broad Spectrum Penicillin
Combinations
• Combination of Amoxicillin with Calvulanic
Acid
• Combination of Ampicillin with Flucoxacillin
• Combination of Ampicillin with Salbactam
• Combination of Ticarcillin with Calvulanic acid
41. 3. Anti pseudomonal Penicillin
• Carbenicillin
• Ticarcillin
• Piperacillin
Are antipesudomonal penicillin because of their
activity against P.aeuroginosa.
Piperacillin is the most potent of these antibiotics.
They are effective against many gram –ive bacilli
but not against klebsiella because of constitutive
penicillinase.
42. Mechanism of Action of Penicillin
• Penicillin are bactericidal. They inhibit the synthesis of
bacterial cell wall. They interfere with last step of cell wall
synthesis (transpeptidation or cross linkage) resulting in
exposure of the osmotic ally less stable membrane. Cell lysis
can occur either through osmotic pressure or through
activation of autolysin.
• These drugs are thus bactericidal, the success of penicillin
antibiotic in causing cell death is related to Antibiotic size,
charge and hydrophobicity.
• Penicillin are effective only against rapidly growing micro
organisms that synthesize peptidoglycan cell wall.
Consequently they are inactive against organisms devoid of
this structure such as mycobacteria, protozoa, fungi and
viruses.
43. 1. Penicillin Binding Protein
• Penicillin inactivate numerous proteins on the bacteria
cell membrane. These penicillin binding protein (PBPs)
are bacterial enzymes involved in the synthesis of cell
wall and in maintenance of morphological features of
bacteria
• Exposure of these antibiotics can therefore not only
prevent cell wall synthesis but also lead to morphological
changes or lysis of susceptible bacteria.
• The number of PBPs varies with type of organisms so
alteration in some of target molecules can cause
resistance For example Methicillin resistant
staphylococcus aureus (MRSA) arose because of this
resistant.
44.
45. 2. Inhibition of Transpeptidase
• Some PBPs catalyze formation of cross linkage
between peptidoglycan chain. Penicillin inhibit
this transpeptidase catalyze reaction, thus
hindering the formation of cross links essential
for cell wall integrity.
46. 3. Production of Autolysin
• Many bacteria particularly Gram +ive cocci produce
degradative enzyme (autolysin) that participate in
normal remodeling of bacterial cell wall.
• In the presence of penicillin, degradative action of
autolysin proceeds in the absence of cell wall
synthesis.
Thus, antibacterial effect of penicillin is result of both
inhibition of cell wall synthesis and destruction of
existing cell wall by autolysin.
47. Resistance
• Natural resistance to penicillin occur in organisms that either lack peptidoglycan
cell wall for example mycoplasma or have cell walls that are impermeable to drug.
Beta lactamase
activity
• This enzyme
hydrolyze cyclic
amide of ß
lactam ring
which result in
loss of
bactericidal
activity.
Decrease
permeability to drug
• Decrease
penetration of
antibiotic through
cell membrane will
prevent the drug
to reach target
PBPS.
• Presence of efflux
pump can also
reduce amount of
intracellular drug.
Altered PBPs
• Modified PBPs
have lower affinity
for ß lactam
antibiotics
requiring clinically
unattainable
concentration of
drug to effect
inhibition of
bacterial growth
48. Pharmacokinetics
• Route of administration of a ß-lactam antibiotic is determined
by the stability of drug to a gastric acid and by severity of
infection.
• After oral administration absorption differs greatly for
different penicillin.
Not absorbed: Carbenicillin, ticarcillin
Moderate absorbed: Benzyl penicillin ( penicillin G),
ampicillin, Cloxacillin
Well absorbed: Phenoxymethyl penicillin ( Penicillin V),
amoxicillin , bacampicillin, Talampicillin, Flucloxacillin,
Ciclacillin.
Absorption
49. Distribution
• After absorption, penicillin's are widely
distributed in body tissue and fluids.
• Entry to CNS is poor.
• This is compensated in treating meningitis by
giving large IV oxacillin and Dicloxacillin.
50. Excretion
• Most of the absorbed penicillin is rapidly excreted by
kidneys into urine.
• About 10% of the renal excretion is by glomerular
filterationand 90% is by tubular secretion.
• Ampicillin is excreted more slowly then penicillin G.
• Naficillin is excreted 80% into bilary tract and only
20% by tubular secretion.
• Penicillin is also excreted in sputum and milk.
• Tubular secretion of penicillin can be partially
blocked by probenecid.
Dose modification is necessary in several renal failure.
51. Adverse Effects of Penicillin
• Non toxic And Safe drugs
• Allergic reactions may be
severe. Major determinant of
penicillin hypersentivity is
penicilloic acid which reacts
with protein and serve as
hapten to cause immune
reaction.
Amoxicillin:
rash 11 hours after
administration
52. Other (Nonallergic) adverse effects
include
• Diarrhoea due to alteration in normal intestinal flora
• Sometimes haemolytic, and thrombocytopenia or
interstitial nephritis.
• Penicillins are presented as their sodium or potassium
salts. Physicians should be aware of this unexpected
source of sodium or potassium, especially in patients
with renal or cardiac disease.
• Neurotoxic: Extremely high plasma penicillin
concentrations cause convulsions. If injected
intrathecally.
• Decrease coaglation maybe observe with high doses of
piperacillin, ticarcillin and nafcillin.
54. Meaning
Cephalosporins are a large group of antibiotics
derived from the mold Acremonium (previously
called Cephalosporium).
55. Introduction
• Cephalosporin are ß-lactam antibiotics that
are closely related both structurally and
functionally to penicillin.
• Most Cephalosporin are produced semi-
synthetically by the chemical attachment of
side chain to 7-aminocephalosporinic acid.
They were first obtained from fungus,
cephalosporium.
56. Molecular Structure
• They have nucleus of 7-aminocephalosporinic
acid instead of penicillin, 6-aminopenicillinic
acid.
β-lactam ring
57. Cephalosporin Mode of Action
• Cephalosporins are a type of β-lactam antibiotic
closely related to the penicillins. They are bactericidal,
with the same MOA as other beta-lactams.
• Cephalosporins disrupt synthesis of the peptidoglycan
layer of bacterial cell walls. Peptidoglycan is a strong
structural molecule specific to the cells walls of
bacteria. With the cell wall structure compromised,
the bactericidal result is lysis and death of the cell.
• Our cells do not have cells walls or peptidoglycan,
therefore, B-lactam antibiotics are able to target
bacterial cells without harming human cells.
58.
59. Classification of Cephalosporin
• They have been classified as 1st , 2nd , 3rd ,4th ,
and fifth generation based largely on their
bacterial susceptibility pattern and resistant to
ß lactamase.
60.
61. First Generation
The first generation of cephalosporin act as penicillin G substitutes.
They are resistant to staphylcoccal penicillanase and also have activity
againstt Proteus mirabilis, E.coli.
Cefazolin
Cefadroxil
Cephalexin
Cephalothin
Cephapirin
Cephradine
• Cefazolin has longer duration of action and similar spectrum of
action compared to other first generation drugs.
• Cephalexin is the prototype of 1st generation oral cephalosporin .
Oral administration twice daily is effective against pharyngitis.
62. Second Generation
• Second generation display greater activity
against 3 additional gram –ive organisms,
H.influenza, Enterobacter aerogenes and
some Neissseria Species whereas activity
against gram +ive bacteria is weaker than 1st
gen.
• Antimicrobial coverage of cefotetan and
cefoxitin also includes the anerobes,
bacteroides fragilis..
63. Cefuroxime sodium
Cefuroxime axetil
Cefmetazole
Cefotetan
Cefaclor
Cefamandole
Cefonicid
Cefoxitin
• Cefuroxime sodium is a prototype 2nd generation parentral
cephalosporin has a longer half life than similar agents. It
cross the BBB and it can be used for community acquired
bronchitis or penumonia or in eldery patient with
immunocompromise.
• Cefuroxime axetil administered twice daily, this drug is well
absorbed and is active ß lactamase producing organism.
64. Third Generation
• These have assumed an important role in
treatment of infectious diseases. 3rd generation
have enhanced activity against gram –ive bacilli as
well as other enteric organisms plus serratia
marcescens ( hosp. acquired infection from catheters)
Cefdinir
Cefixime
Cefotaxime
Ceftazidime
Ceftibuten
Ceftriaxone
cefoperazone
65. • Ceftriaxone and cefotaxime have become agent of
choice in treatment of meningitis.
• Cefidinir and Cefixime are administered orally once
daily.
• Cefotaxime penetrate well into CSF.
• Ceftazidime is active against Pseudomonas aeruginosa.
• Ceftriaxone has longest half life of any cephalosporin
(6-8hr) which permits once a daily dosing. High level of
this drug can be achieved in blood and CSF. it is
effective against genital, anal and pharyngeal penicillin
resistant Neisseria gonorrhea.
• Ceftriaxone is excreted in bile and maybe use in
patient with renal insufficiency. It has good penetration
in bone.
66. Fourth Generation
Cefepime is classified as 4th generation of
cephalosporin and must be administered parenterally.
Cefepime has a wide antibacterial spectrum, being
active against streptococci and staphylococci ( but only
those that are methicillin susceptible)
Cefepime is also effective against gram –ive micro
organism such as E.coli , K. penumoniae.
71. Distribution
• All cephalosporin distribute very well into
body fluids. However, adequate therapeutic
level in CSF, regardless of inflammation are
achieved.
• Only with a select a few cephalosporin For
example, ceftriaxone or cefotaxime is effective
in treatment of neonatal and childhood
meningitis caused by H.influenzae.
72. Elimination
• Elimination occurs through tubular secretion or
glomerular filtration.
• Therefore doses must be adjusted in case of
severe renal failure to guard against
accumulation and toxicity.
• An exception is ceftriaxone which is excreted
through bile into feces and therefore is
frequently employed in patients with renal
insufficiency.
73.
74. Adverse Drug Reactions
• Incidence of adverse effects with
cephalosporin Is relatively low.
Allergy: allergic reactions of
penicillin type is cross allergy
between penicillin and
cephalosporin's in about 10%
patient. If a patient had a severe on
immediate allergy reaction to
penicillin then cephalosporin
should not be used.
75. Other Common ADRs are:
• Diarrhea
• Nausea
• Rash
• Electrolyte Disturbances
• Super infection
78. Carbapenems
• Are synthetically ß-lactam antibiotics that differ
in structure from penicillin in sulfur atom of
thiazolidine ring has been externalized and
replaced by carbon atom.
Members:
• Imipenem
• Meropenem
• Doripenem
• Eratapenem
79. • They are broad spectrum antibiotic active
against many aerobics and anaerobics. Gram
+ive and gram –ive organisms.
• They are highly resistant to ß- lactamase
enzyme, making them very useful in treating
bacterial infection. Where ß-lactamase is
produce that make other ß-lactam antibiotics
ineffective.
80. Monobactams
• Monobactam which also disrupt cell wall
synthesis. They are unique because ß-
lactam is alone not fuse to any other.
• Aztreonam , is only commercially
available moobactam, has antimicrobial
activity directed primarily against
enterobacteriaceae, including
P.aerugionsa. It lacks activity against
gram +ive organism and anaerobes.
• Aztreonam may offer a safe alternative
for treating patients who are allergic and
unable to tolerate penicillin or
cephalosporin.
81. ß- Lactamase Inhibitors
• Hydrolysis of ß lactam ring either by enzymatic
cleavage with ß-lactamases or by acid, destroy
the antimicrobial activity of ß-lactam
antibiotic.
ß- lactamase inhibitors include:
• Clavulanic acid
• Salbactam
• Tezobactam
82. • ß lactamase inhibitors contain a ß-
lactam ring but by themselves do not
have significant antibacterial activity,
Instead they bind to and inactivate ß-
lactamase thereby protecting ß-lactam
antibiotics that are normally substrate
for this enzyme.
• The ß-lactamase inhibitors are
therefore formulated in combination
with ß –lactamase sensitive antibiotics.
• For example, Calvulanic acid +
amoxicillin ( Co-Amoxiclav)
84. Vancomycin
• Vancomycin is an antibiotic ( tricyclic
glycopeptide) that has become increasingly
important because of its effectiveness against
multiple drug resistant organisms, such as
MRSA and enterococci.
• it is active against wide variety of gram +ive
bacteria.
• It acts by inhibiting cell wall synthesis by
peptidoglycan polymerization.
85. Adverse Effects
• Fever
• Chill
• Phlebitis at infusion site
• Ototoxicity and nephrotoxicity are more
common when administered with another
drug.
86. Daptomycin
• It is a cyclic lipopeptide antibiotic, use in
treatment of systemic and life threatening
infections cause by gram+ive organisms.
87. Mechanism
• Upon binding to bacterial cytoplasmic membrane,
daptomycin induce rapid depolarization of membrane thus
disrupting multiple aspects of membrane function and
inhibiting intracellular synthesis of DNA, RNA and proteins.
• Daptomycin is bactericidal and bacteria killing is
concentration depending
88. Telavancin
• Telavancin is a semi synthetic lipoglycopeptide
antibiotic that is synthetic derivative of vancomycin.
• It is alternative to vancomycin, daptomycin in
treating complicated skin and skin structure
infections caused by resistant gram +ive organism
including MRSA.
• Like vancomycin it also inhibit bacterial cell wall
synthesis .
• Unlike vancomycin, it exhibit an additional
mechanism of action similar to daptomycin that
involved distrutpion of bacterial cell membrane due
to presence of liphophilic side chain moiety.
92. AminoGlycosides
• Aminoglycosides are a group of bactericidal
drug originally obtained from various
streptomyces species.
• Aminoglycoside antibiotics is associated with
serious toxicities. They have been replaced to
some extent by safer antibiotics, such as third
and fourth generation of cephalosporins, the
fluoroquinolones and the carbapenem.
94. Mechanism of action
• Aminoglycoside are bactericidal drugs
• They cause the irreversible inhibition of bacterial protein synthesis.
• After penetration through cell wall by active transport process as well
as passive diffusion, the drug binds to receptors on 30S subunit of
bacterial ribosome.
95. Inhibition of ribosomal protein
synthesis is done by at least 3 ways
1. Interference with initiation complexes of
peptide formation
2. Misreading of code on mRNA template which
cause incorporation of incorrect amino acid
into peptide
3. Breaking up of polysomes into non functional
monosome.
96. Resistance
1. By decreased uptake of drug when oxygen dependent
transport system for aminoglycoside is absent.
2. The micro organism produces a transferase enzyme or an
enzyme that inactivate the aminoglycoside by
adenylylation, acetylation or phosphorylation. This is
principle type of resistance encountered clinically
3. The receptor protein on 30S ribosomal subunit maybe
deleted or altered as a result of a mutation
97. Pharmacokinetics
• Aminoglycoside are water soluble and do not readily
cross cell membrane
• They are not absorbed from gut and therefore must
be given by injection for systemic infection
• Penetration in CSF is poor.
• Penetration in bile is moderate
• Aminoglycoside cross placenta and may cause
damage to 8th nerve un fetus.
• There is no significant biotransformation.
• Plasma half life is 2-4 hr
• Excretion is mainly by glomerular filtration.
98. Therapeutic Use
• Aminoglycoside are mainly used for:
1. Serious infection caused by gram –ive bacilli
particularly septicemia, pelvic and abdominal
sepsis.
2. They are almost always used in combination
with ß-lactam antibiotic to extend coverage
to include potential gram+ive pathogen.
99. Adverse Effects
It is imp to monitor plasma levels of gentamicin,
tobramycin and amikacin to avoid concentration
that cause dose related toxicities.
1. Ototoxicity: directly related to higher peak
plasma level and duration of treatment
2. Nephrotoxicity: retention of aminoglycoside by
proximal tubular cells result in kidney damage.
100. Macrolides
• Macrolide are a group of closely related
compounds characterized by a macrocyclic
lactone ring ( usually containing 14 or 16 atoms)
to which deoxysugars are attached.
• The prototype drug, erythromycin which consist
of two sugar moieties attached to a 14 atom
lactone ring, was obtained in 1952 from
streptomyces erythreus. Clarithromycin and
azithromycin are semi synthetic derivative of
erythromycin.
101.
102. Mechanism of action
• It is primarily bacteriostatic drug.
• It inhibits bacterial protein synthesis
• It binds irreversibly to a site on 50S sub unit of
bacterial ribosome, thus inhibiting
translocation step of protein synthesis.
• They also interfere at other step such as
transpeptidation.
103.
104.
105. Resistance
• Resistance to erythromycin is usually plasmid
encoded. Three mechanisms have been
identified.
1. Reduced permeability of cell membrane or
active efflux
2. Production ( by enterobacteriaceae, large family
of gram-ive) esterases that hydrolyze macrolide
3. Modification of ribosomal binding site by
chromosomal mutation.
106. Antibacterial Spectrum
Erythromycin: Is effective against many of same organism as penicillin G
(streptococci etc)
Telithromycin: has similar antibacterial spectrum similar to azithromycin
Clarithrmycin: has spectrum of antibacterial activity similar to
erythromycin but it is also effective against Haemophilus influenza,
H.pylori
Azithromycin: although less active against streptococci and
staphylococci than erythromycin, azithromycin is far more active against
respiratory infections (Bordetella pertussis and Legionella species. It
also has activity against Mycoplasma pneumoniae, Treponema pallidum,
Chlamydia species and Mycobacterium avium complex.)
107. Pharmacokinetic
• Erythromycin base is destroyed by stomach acid and
must be administered with enteric coating or esterified.
• Food interferes with absorption
• Clarithromycin, Azithromycin and Telithromycin are
stable to stomach acid and are readily absorbed.
• Erythromycin distributes well in body fluids except CSF. It
is one of the few antibiotics that distributes in prostatic
fluid and it has a unique characteristic of accumulating in
marophages
• All drugs concentrate in liver
• Adjustment of renal failure is not necessary because they
excreted in bile.
108. Adverse Effects
1. Epigastric Distress: This is common
side effect and can lead to poor
patient compliance to erythromycin
2. Cholestatic Jaundice ( retention of
the constituents of bile in blood):
Occurs with estolate forms of
erythromycin.
3. Ototoxicity: Transient Deafness has
been associated with erythromycin
especially at high dosage
4. Other Allergic Reactions include
fever, esinophilia and rashes
110. Interactions
• Erthromycin, Telithromycin and clarithromycin inhibit
hepatic metabolism of a no. of drugs which can lead to
toxic accumulation of these compounds.
• No interactions have been reported for azithromycin
111. Clinical Uses
Erythromycin is a drug of choice
• in cornyebacterium infection
( diphtheria),
• in respiratory infections,
• neonatal, occular or genital
chlamydial infections
• and in treatment of
community acquired
penumonia.
113. Chloramphenicol
• It is active against a wide range of gram+ive and gram –
ive organisms (bacteria, spirochetes, rickettsiae,
chlamydiae and mycoplasmas.). However, because of
its toxicity, its use is restricted to life threatning
infections for which no alternative exist.
• Chloramphenicol was first isolated in 1947 from culture
of streptomyces venezulae
114. Mechanism of Action
• The drug binds to bacterial
ribosomal 50S subunit and
inhibit protein synthesis at the
peptidyltransferase reaction.
Because of similarity of
mammalian mitochondrial
ribosomes to those of
bacterial ribosomes, protein
synthesis in these organelles
maybe inhibited at high conc
in blood producing bone
marrow toxicity.
115. Adverse Drug Reaction
1. GI- Disturbances Nausea , vomiting, Diarrhea
2. Bone Marrow Disturbances: Anemia
3. Grey baby syndrome: this occurs in neonate if dosage regimen of
chloramphenicol is not properly adjusted . Neonate have a low capacity
to glucuronylated the antibiotic and they have underdeveloped renal
function. Therefore neonate have decrease ability to excrete the drug,
which accumulate to level that interfere with function of mitochondrial
ribosome. this lead to poor feeding, depressed breathing, cardiovascular
collapse, cyanosis ( hence name grey baby) and death.
Adults can also exhibit this toxicity at high doses.
117. TUBERCULOSIS
• Chronic disease caused by Mycobacterium tuberculosis.
• Tuberculosis typically attacks the lungs, but can also affect other
parts of the body.
• It is spread through the air when people who have an active TB
infection cough, sneeze, or otherwise transmit respiratory fluids
through the air.
118. Drugs used in TB
FIRST LINE
Isoniazid
Rifampicin
Pyrazinamide
Ethambutol
Streptomycin
SECOND LINE
Ethionamide
Thiacetazone
Para Aminosalicylic acid (PAS)
Amikacin
Capreomycin
Cycloserine
Ciprofloxacin
Kanamycin
Rifabutin
Rifapentine
*RIPES
119. Isoniazid
PHARMACOKINETICS
Absorption
• Rapid and complete; rate can be slowed with food
• Peak Plasma Time: 1-2 hr
Distribution
• All body tissues and fluids including CSF; crosses placenta; enters breast
milk
• Protein Bound: 10-15%
Metabolism
• Hepatic
Elimination
• Excretion: Urine (75-95%); feces
120. Mechanism of Action
• isoniazid targets the enzymes acyl carrier protein reductase (InhA) and
β-ketoacyl-ACP synthase (KasA), which are essential for the synthesis
of mycolic acid. Inhibiting mycolic acid leads to a disruption in the
bacterial cell wall.
Interactions:
• INH can increase CBZ concentrations and cause CBZ toxicity.
• Aluminum salts, decrease the absorption of INH.
• INH may inhibit valproic acid hepatic metabolism.
Contraindications:
• Acute liver disease.
• Lactation,seizure disorder.
121. ADRs
• Hepatitis
• Peripheral neuropathy
• convulsions in patients prone to seizures
• Hypersensitivity reactions with isoniazid include rashes and fever.
122. RIFAMPICIN
Rifampin is a semisynthetic derivative of rifamycin,
an antibiotic produced by Streptomyces
mediterranei.
It is active against gram positive and gram negative
cocci, some enteric bacteria, mycobacteria and
chlamydia.
Mechanism
• Rifampin binds to the β subunit of bacterial
DNA–dependent RNA polymerase and thereby
inhibits RNA synthesis.
• Resistance results from any one of several
possible point mutations in repoB, the gene for
the β subunit of RNA polymerase.
123.
124. Pharmacokinetics
Absorption
• PO well absorbed; food may delay absorption
• Peak plasma time: 2-4 hr
Distribution
• crosses blood-brain barrier well.
• Protein bound: 80%
Metabolism
• Metabolized by liver.
Elimination
• Half-life: 3-4 hr (prolonged in hepatic impairment); in end-stage renal
disease, 1.8-11 hr
• Excretion: Feces (60-65%) and urine (~30%) as unchanged drug
125. • Adverse effects: Rifampin is generally well tolerated. The most
common adverse reactions include nausea, vomiting, and rash.
Hepatitis and death due to liver failure are rare.
• Drug interactions: Because rifampin induces a number of
cytochrome P450 enzymes, it can decrease the half-lives of co
administered drugs that are metabolized by these enzymes. This
may necessitate higher dosages for co administered drugs, a switch
to drugs less affected by rifampin, or replacement of rifampin with
rifabutin.
126. Pyrazinamide
Pharmacokinetics
• Absorption: well absorbed
• Distribution: widely into body tissues and fluids including liver, lung,
and CSF
• Protein binding: 50%
• Metabolism: hepatic
• Half-life elimination: 9-10 hr
• Time to peak, serum concentration: within 2 hr
• Excretion: urine (4% as unchanged drug)
127. Mechanism of Action
Pyrazinamide's exact mechanism of action is not known. Susceptible
strains release pyrazinamidase, which converts PZA to pyrazinoic acid
(POA). POA decreases the pH below that which retards the growth
of M. tuberculosis and inhibiting the fatty acid synthesis .Studies
indicate that PZA is most effective in the initial stages of treatment,
which may be the result of diminished organism populations in
macrophages early in therapy.
128. Adverse Effects
• 1-10%: Malaise ( general feeling of discomfort, illness), Nausea, Vomiting , Anorexia,
Arthralgia (pain in a joint), Myalgia (pain in a muscle)
• <1%: Fever, Rash, Itching, Acne, Photosensitivity, Gout, Dysuria (the sensation of pain
and/or burning, stinging, or itching of the urethra or urethral meatus associated with
urination), Porphyria (a group of liver disorders in which substances called porphyrins build
up in the body, negatively affecting the skin or nervous system), Thrombocytopenia
(deficiency of platelets in the blood), Hepatotoxicity, Interstitial nephritis ( the spaces
between the kidney tubules become swollen (inflamed)).
Interactions
• PZA can increase serum uric acid levels and precipitate gout attacks, the dosages of
antigout agents, including allopurinol, colchicine, probenecid , and sulfinpyrazone may
need to be adjusted.
• PZA is associated with dose-related hepatoxicity. Daily use of ethanol while receiving
pyrazinamide increases the risk of drug-induced hepatitis.
129. Ethambutol
Pharmacokinetics
Absorption
• Bioavailability: ~80%
• Peak Plasma Time: 2-4 hr
Distribution
• Widely throughout body.
• Protein binding: 20-30%
Metabolism
• Hepatic (20%) to inactive metabolite
Elimination
• Half-life elimination: 2.5-3.6 hr; 7-15 hr (end-stage renal disease)
• Excretion: ~50% urine; ~50% feces as unchanged drug.
130. Mechanism
Ethambutol inhibits mycobacterial arabinosyl
transferases. Arabinosyl transferases are
involved in the polymerization reaction of
arabinoglycan, an essential component of the
mycobacterial cell wall.
ADRS
• Acute gout or hyperuricemia, Abdominal pain,
Anaphylaxis, Confusion, disorientation, Fever,
Headache, LFT abnormalities, Malaise,
Nausea
• Optic neuritis; symptoms may include
decreased acuity (ability of the eye to distinguish
shapes and the details of objects at a given
distance), color blindness or visual defects
(usually reversible with discontinuation).
• Rash
Drug Interactions
• Aluminum hydroxide can reduce the rate or
extent of ethambutol absorption. At least 4
hours should elapse between doses of
aluminum hydroxide-containing antacids and
ethambutol.
132. Anti-viral drugs
• Viruses have no cell wall and made up of
nucleic acid components
• Viruses containing envelope – antigenic in
nature
• Viruses are obligate intracellular parasite
• They do not have a metabolic machinery of
their own – uses host enzymes
133. Anti-viral drugs
• Certain viruses multiply in the cytoplasm
but others do in the nucleus
• Most multiplication take place before
diagnosis is made
134. Anti-Viral drugs
• Many antiviral drugs are Purine or
Pyrimidine analogs.
• Many antiviral drugs are Prodrugs. They
must be phosphorylated by viral or cellular
enzymes in order to become active.
• Anti-viral agents inhibits active replication
so the viral growth resumes after drug
removal.
135. Anti-viral drugs
• Current anti-viral agents do not eliminate
non-replicating or latent virus
• Effective host immune response remains
essential for the recovery from the viral
infection
• Clinical efficacy depends on achieving
inhibitory conc. at the site of infection
within the infected cells
141. Anti-viral drugs
Acyclovir & Congeners :
• Valacyclovir is a prodrug of Acyclovir with
better bioavailability.
• Famciclovir is hydrolyzed to Penciclovir
and has greatest bioavailability.
• Penciclovir is used only topically whereas
Famciclovir can be administered orally.
142. Anti-Viral drugs
PHARMACOLOGY OF ACYCLOVIR AND
CONGENERS
• Acyclovir, Valacyclovir, Ganciclovir,
Famciclovir, Penciclovir all are guanine
nucleoside analogs.
143. Anti-viral drugs
Mechanism of action of Acyclovir and
congeners :
• All drugs are phosphorylated by a viral
thymidine-kinase, then metabolized by
host cell kinases to nucleotide analogs.
• The analog inhibits viral DNA-polymerase
• Only actively replicating viruses are
inhibited
144. Mechanism: ( Easy One)
– Three phosphorylation steps for activation.
• First converted to the monophosphate derivative by the
virus-specified thymidine kinase;(selective activation)
• Then to the di- and triphosphate compounds by host’s
cellular enzymes.
– Acyclovir triphosphate inhibits viral DNA synthesis
by two mechanisms:
• Competitive inhibition of deoxyGTP for the viral DNA
polymerase, with binding to the DNA template as an
irreversible complex;
• Incorporation into the viral DNA → chain termination
145.
146. Anti-viral drugs
• Acyclovir is thus selectively activated in
cells infected with herpes virus.
• Uninfected cells do not phosphorylate
acyclovir.
147. Anti-Viral drugs
Antiviral spectrum :
• Acyclovir: HSV-1( is typically transmitted by oral-to-oral contact and
causes infection in or around the mouth (oral herpes), but it can also
cause genital herpes), HSV-2 ( is mainly sexually transmitted and
causes genital herpes), VZV (chickenpox and herpes zoster
(shingles))
• Ganciclovir / Cidofovir : CMV (mononucleosis or hepatitis (liver
problem).)
• Famciclovir : Herpes genitalis and shingles (painful rash)
• Foscarnet : HSV, VZV, CMV, HIV
• Penciclovir : Herpes labialis ( rash of the skin and mucous
membranes,in particular, the lips))
• Trifluridine : Herpetic keratoconjunctivitis
148. Anti-Viral drugs
Pharmacokinetics of Acyclovir :
• Oral bioavailability ~ 20-30%
• Distribution in all body tissues including
CNS
• Renal excretion: > 80%
• Half lives: 2-5 hours
• Administration: Topical, Oral , IV
149. Anti-viral drugs
Adverse effects of Acyclovir /
Ganciclovir
• Nausea, vomiting and diarrhea
• Nephrotoxicity - crystalluria, haematuria,
renal insufficiency
• Myelosuppression – Neutropenia and
thrombocytopenia – Ganciclovir (a
condition in which bone marrow activity is
decreased, resulting in fewer red blood cells,
white blood cells, and platelets)
150. Anti-viral drugs
Therapeutic uses :
Acyclovir is the drug of choice for:
• HSV Genital infections
• HSV encephalitis
• HSV infections in immunocompromised patient
Ganciclovir is the drug of choice for:
• CMV retinitis in immunocompromised patient
• Prevention of CMV disease in transplant patients
151. Anti-viral drugs
Cidofovir :
• It is approved for the treatment of CMV
retinitis in immunocompromised patients
• It is a nucleotide analog of cytosine – no
phosphorylation required.
• It inhibits viral DNA synthesis
• Available for IV, Intravitreal inj, topical
• Nephrotoxicity is a major disadvantage.
152. Anti-viral drugs
PHARMACOLOGY OF VIDARABINE
• Vidarabine is a nucleoside analog.
(adenosine)
Antiviral spectrum of Vidarabine :
HSV-1, HSV-2 and VZV.
Its use is limited to HSV keratitis only
153. Anti-viral drugs
Vidarabine
• The drug is converted to its
triphosphate analog which inhibits
viral DNA-polymerase.
• Oral bioavailability ~ 2%
• Administration: Ophthalmic
ointment
• Used in HSV keratoconjunctivitis
in immunocompromised patient.
• Anemia and SIADH (Syndrome of
inappropriate antidiuretic hormone
secretion) are adverse effects.
154. Anti-viral drugs
PHARMACOLOGY OF
TRIFLURIDINE
• Trifluridine is a Pyrimidine
nucleoside analogs - inhibits viral
DNA synthesis.
Antiviral spectrum Trifluridine :
• HSV-1, HSV-2 and VZV.
• Use is limited to Topical - Ocular
HSV Keratitis
155. Anti-viral drugs
PHARMACOLOGY OF FOSCARNET
• Foscarnet is an inorganic pyrophosphate
analog
• It directly inhibits viral DNA and RNA -
polymerase and viral inverse transcriptase
(it does not require phosphorylation for
antiviral activity)
156. Anti-viral drugs
Foscarnet
• HSV-1, HSV-2, VZV, CMV and HIV.
• Oral bioavailability ~ 10-20%
• Distribution to all tissues including CNS
• Administration: IV
157. Anti-viral drugs
Adverse effects of Foscarnet
• Hypocalcemia and hypomagnesemia (due
to chelation of the drug with divalent
cations) are common.
• Neurotoxicity (headache, hallucinations,
seizures)
• Nephrotoxicity (acute tubular nephrosis is
a condition that causes the lack of oxygen
and blood flow to the kidneys, damaging
them, interstitial nephritis)
158. Anti-viral drugs
Therapeutic uses of Foscarnet
• It is an alternative drug for
• HSV infections (acyclovir resistant /
immunocompromised patient )
• CMV retinitis (ganciclovir resistant /
immunocompromised patient )
160. Anti-viral drugs
Amantadine and
Rimantadine :
Influenza (A,B,C,D)
• Prevention & Treatment
of influenza A
• Inhibition of viral
uncoating by inhibiting
the viral membrane
protein M2 OF Influenza
A virus
• Amantadine has anti-
parkinsonian effects.
161.
162. Anti-viral drugs
Pharmacokinetics of Amantadine
• Oral bioavailability ~ 50-90%
• Amantadine cross extensively BBB
whereas Rimantadine does not cross
extensively .
• Administration: Oral
163. Anti-viral drugs
Neuraminidase inhibitors : Influenza
Oseltamivir / Zanamavir
• Influenza contains an enzyme
neuraminidase which is essential for the
replication of the virus.
• Neuraminidase inhibitors prevent the
release of new virions and their spread
from cell to cell.
164. Anti-viral drugs
Neuraminidase inhibitors : Influenza
Oseltamivir / Zanamavir
• These are effective against both types of
influenza A and B.
• Do not interfere with immune response to
influenza A vaccine.
• Can be used for both prophylaxis and
acute treatment.
166. Anti-viral drugs
Neuraminidase inhibitors : Influenza
Oseltamivir / Zanamavir
• Oseltamivir is orally administered.
• Zanamavir is given intranasal.
• Risk of bronchospasm with zanamavir
167. Anti-viral drugs
PHARMACOLOGY OF RIBAVIRIN
• Ribavirin is a guanosine analog.
• Inhibition of RNA polymerase
Antiviral spectrum : DNA and RNA viruses
are susceptible, including influenza,
parainfluenza viruses, RSV, Lassa virus
168. Anti-viral drugs
Ribavirin : RSV (Respiratory syncytial virus)
• Distribution in all body tissues, except CNS
• Administration : Oral, IV, Inhalational in
RSV.
• Anemia and jaundice are adverse effects
• Not advised in pregnancy.
169. Anti-viral drugs
Therapeutic uses Ribavirin
Ribavirin is the drug of choice for:
• RSV bronchiolitis and pneumonia in
hospitalized children (given by aerosol)
• Lassa fever
Ribavirin is an alternative drug for:
• Influenza, parainfluenza, measles virus
infection in immunocompromised patients
171. Anti-viral drugs
Interferons
Interferons (IFNs) are natural proteins
produced by the cells of the immune
systems in response to challenges by
foreign agents such as viruses, bacteria,
parasites and tumor cells.
• Antiviral, immune modulating (modify
immune response) and
anti-proliferative actions (inhibit growth)
• Three classes of interferons – α , β, γ
172.
173. Interferons
• α and β interferons are produced by all the
cells in response to viral infections
• γ interferons are produced only by T
lymphocyte (a lymphocyte of a type produced or
processed by the thymus gland and actively
participating in the immune response) and NK (a
type of white blood cell) cells in response to
cytokines – immune regulating effects
• γ has less anti-viral activity compared to α and
β interferons
174.
175. Mechanism of action of Interferons :
• Induction of the following enzymes:
1) a protein kinase which inhibits protein
synthesis
2) an oligo-adenylate synthase which leads
to degradation of viral mRNA
3) a phosphodiesterase which inhibit t-RNA
The action of these enzymes leads to an
inhibition of translation
176. Anti-viral drugs
Antiviral spectrum : Interferon α
• Includes HBV, HCV and HPV (Human
papillomavirus).
• Anti-proliferative actions may inhibit the growth of
certain cancers - like Kaposi sarcoma (disease in
which cancer cells are found in the skin or mucous
membranes that line the gastrointestinal (GI) tract,
from mouth to anus, including the stomach and
intestines.) and hairy cell leukemia (a type of cancer
in which the bone marrow makes too many
lymphocytes).
177. Anti-viral drugs
Pharmacokinetics : Interferons
• Oral bioavailability: < 1%
• Administered Intralesionally, S.C, and I.V
• Distribution in all body tissues, except CNS
and eye.
• Half lives: 1-4 hours
179. Anti-viral drugs
Therapeutic uses Interferons
• Chronic hepatitis B and C (complete disappearance is seen
in 30%).
• HZV infection (Herpes zoster, also known as shingles) in
cancer patients (to prevent the dissemination of the
infection)
• CMV infections in renal transplant patients
• Condylomata acuminata (given by intralesional injection).
Complete clearance is seen ~ 50%.
• Hairy cell leukemia (in combination with zidovudine)
• AIDS related Kaposi’s sarcoma
181. VZV
In normal host No therapy
In immunocompro-
mised host, or during
pregnancy
Acyclovir Foscarnet
CMV Retinitis Ganciclovir Foscarnet
HIV
AIDS
HIV antibody
positive with CD4
count < 500/mm3
Zidovudine ±
protease
inhibitors
Didanosine,
Stavudine
HBV
HCV
Hepatitis B, C Interferons
183. Introduction
• Human fungal infection have increased dramatically in
incidence and severity in recent years due to mainly
advances in surgery, cancer treatment and critical care
accompained by increase in use of broad spectrum
antimicrobial and HIV.
• Infectious diseases caused by fungi are called mycoses
and they are often chronic in nature.
• Some mycotic infections are superficial and some
involve skin but fungi may penetrate into skin causing
sub cutaneous infections.
• The fungal infection that are most difficult to treat are
systemic mycoses, which are often life threatening.
184. • Unlike bacteria, fungi are eukaryotic (Nucleus).
They have rigid cell walls composed of largely of
chitin rather than peptidoglycan.
• The fungal cell membrane contain ergosterol
rather than cholesterol found in mammalian
membrane. These Chemical characteristic are in
targeting chemotherapeutic agents against fungal
infections.
• Fungal infections are generally resistant to
antibiotics used in treatment of bacterial infection
and conversely bacteria are resistant to antifungal
agents.
185.
186. Classification of Antifungal Drugs
1. Drugs for Sub cutaneous and systemic mycoses :
• Amphotericin B
• Andidulafungin
• Caspofungin
• Fluconazole
• Flucocytosine
• Itraconazole
• Ketoconazole
• Micafungin
• Posaconazole
• voriconazole
Mycoses that cause superficial infections
of the epidermis, hair, and nails, are called
cutaneous mycoses. Mycoses that
penetrate the epidermis and the dermis
to infect deeper tissues are called
subcutaneous mycoses.
189. 1. Amphotericin B
• Amphotericin B is a naturally occurring
polyene macrolide antibiotic produced by
streptomyces nodosus.
• Inspite of its toxicity, Amphotericin B is a drug
of choice for treatment of systemic mycoses.
190. Mechanism of action
• Several amphotericin B molecule bind to ergosterol
in plasma membrane of sensitive fungal cell they
form pores (channels) that require hydrophobic
interactions between lipophilic segment of polyene
antibiotic and the sterol.
• The protein disrupts membrane function, allowing
electrolytes ( particularly postassium) and small
molecules to leak from cell, resulting in cell death.
191. PHARMACOLOGY OF AMPHOTERICIN B
Chemistry
-Amphotericin B is a polyene antibiotic (polyene: containing
many double bonds)
Mechanism of action
-Binding to ergosterol present in the membranes of fungal cells
Formation of “pores” in the membrane
Leaking of small molecules (mainly K+) from the cells
-The ultimate effect may be fungicidal or fungistatic
depending on the organism and on drug concentration.
192. Antifungal Spectrum
Amphotericin B is either fungicidal or fungistatic
depending upon the on the organism and
concentration of drug. It is effective against a
wide range of fungi including:
• Candida albican (is a naturally occurring
fungus that lives on your body)
• Histoplama capsulatum (is an environmental
dimorphic fungus)
• Cryptococcus neroforman (fungus that lives
in the environment throughout the world.)
• Aspergillus (Aspergillus is a genus consisting
of several hundred mold species found in
various climates worldwide.)
193. Pharmacokinetic
• Amphotericin B is administered by slow, Iv infusion.
• The most dangerous intrathecal route is chosen for
treatment of meningitis caused by fungi that are sensitive
to drug
• Amphotericin B has also been formulated with a variety of
artificial lipids that form liposome
• Amphotericin B is extensively bound to plasma proteins
and is distributed throughout the body becoming highly
bound tissue.
194. • Low level of drug and its metabolite appear in
urine over a long period of time and some are
also eliminated via bile.
• To avoid nephrotoxicity, alternatives including
sodium loading with infusion of normal saline
and lipid base amphotericin B products are
used.
195. Adverse Effects
• Amphotericin B has low therapeutic index.
1. Fever and Chills: These occurs most commonly 1
to 3 hr after starting IV administration but they
are usually subside with repeated administration
2. Renal Impairment: Despite the low level of drug
excrete in urine patient may exhibit a decrease
in glomerular filtration rate. Creatanine
clearance can drop and K and Mg can are lost.
196. 3. Hypotension: A shock life fall in blood
pressure accompained by hypokalemia may
occur, require potassium supplimentation
4. Anemia can occur due to suppression of
erythropoietin production
5. Neurologic Effects can be seen with
intrathecal administration of drug.
6. Thrombophlebitis (blocking due
To clots)
197. Liposomal preparations of amphotericin B
• Amphotericin B is packaged in a lipid- associated
delivery system to reduce binding to human cell
membrane , so reducing :
• A. Nephrotoxicity
• B. Infusion toxicity
• Also, more effective
• More expensive
198. 2. Flucytosine (5-FC)
• Flucytosine is a synthetic pyrimidine
antimetabolite (inhibit metabolism)
• that is often use in combination with
amphotericin B.
199. Mechanism of action
• 5 F-C (flucytosine) is taken by fungal cells via
enzyme cytosine premase
• It is converted intracellulary first to 5 FU and
then to 5- fluorodeoxyuridine monophosphate
(F-dUMP) and fluorouridine triphosphate
(FUTP) which inhibits DNA & RNA synthesis
respectively
• Human cells are unable to convert parent drug
into its active metabolite
205. Mechanism of action
• Azoles are predominantly fungi static.
• They inhibit C-14 α-demethylase ( a cytochrome P450 enzyme)
thereby blocking the demethylation of lanosterol to ergosterol.
The principle sterol of fungal membrane.
• This inhibition disrupts membrane structure and function which in
turn inhibits fungal cell growth.
• Azoles are relatively Non-toxic
• Most common adverse reaction is relatively minor gastrointestinal
upset.
206. Drug Interaction & Contraindication
• All azoles have been reported to cause
abnormalities in liver enzyme.
• By inhibiting cypP450, ketoconazole can
potentiate the toxicities of other drugs such as
cyclosporine and phenytoin and warfarin
• Ketoconazole and amphotericin B should not
be use together because the decrease in
ergosterol in fungal membrane reduce the
fungicidal action of amphotericin B.
209. Echinocandins
• Echinocandins are antifungal drugs that inhibit
the synthesis of glucan in cell wall via
inhibition of all enzyme 1,3 ß glucan synthase.
• 3 drugs from this class are currently used
clinically:
– Caspofungin
– Micafungin
– Anidulafungin
210. Caspofungin
• It is the first member of echocandins class of
antifungal drugs.
• Caspofungin has activity against aspergillus
and most candida species including those
species that are resistant to azoles.
211. Adverse Effects include
• Fever
• Rash
• Nausea
• Phlebitis (inflammation of the walls of a vein)
• Flushing occur due to release of histamine
from mast cell
212. Drugs for cutaneous mycotic Infection
• Mold like fungi that cause cutaneous skin
infections are called dermatophytes or tinea.
• These tinea are classified by the site of their
infection such as tinea pedis, which refers to
an infection of feets.
213. Squalene Epioxidase Inhibitor
• These agents act by inhibiting squalene
epioxide, resulting in blocking of biosynthesis
of ergosterol, an essential component of
fungal cell membrane.
Drugs:
1. Terbinafine
2. Naftifine
3. Butenafine
214. Terbinafine
• Oral terbinafine is a drug of choice for treating
dermatophytoses especially onychomycoses
(Nail infection)
• Terbinafine hydrochloride, also known under
the trade name Lamisil,is a synthetic
allylamine antifungal developed by Novartis. It
is highly hydrophobic in nature and tends to
accumulate in skin, nails, and fatty tissues.
215. Mechanism of Action
• Like Azole drugs, it interfere with ergosterol
biosynthesis but rather than interacting with P450
system, terbinafine inhibits the fungal enzyme
squalene epioxide. This leads to accumulation of sterol
squalene which is toxic to organism.
• Squalene epioxide is the enzyme that govern the
conversion of squalene into ergosterol ( the major
component of fungal cell membrane). If squalene
epioxide is inhibited it will not converted to ergosterol
and hence squalene starts accumulating in fungal cell,
which leads to fungal cell death.
216. Antifungal Spectrum
• The drug is primarily fungicidal. Topical
terbinafie 1% cream and soultion are used to
treat tinea pedis, tinea corporis ( Scalp), and
tinea cruris ( groin area).
217. Griseofulvin
• Griseofulvin has been largely replaced by oral
terbinafine for the treatment of
dermatophytic infections of the nails,
although it is still used for ring worm and
dermatophytosis of the skin and hair.
218. Mechanism of action
• Griseofulvin mechanism of action at cellular level
is unclear but it is deposited in newly forming
skin where it binds to keratin, protecting skin
from new infection.
• Since its action is to prevent infection of these
new skin structures, it must be administered for
2-6 weeks for skin and hair infection to allow
replacement of infected keratin by resistant
structure.
• Nail infection may require therapy for months to
allow regrowth of protected nail.
219.
220.
221.
222. Other drugs are:
• Nystatin ( binds to ergosterol in the fungal cell
membrane, which leads to the formation of
pores, ion leakage and ultimately fungal cell
death)
• Imidazole include ( Butoconazole, Clotrimazole,
Oxiconazole, Ecoconazole etc),work as azole
• Ciclopirox (Ciclopirox inhibit transport of essential
elements thus result in Disruption of RNA , DNA
and protein synthesis in fungal cell)
• Tolnaftate (inhibit ergosterol synthesis)
224. Introduction to anthelmintics
• Anthelmintics are drugs that are used to treat
infections with parasitic worms. This includes
both flat worms, e.g., flukes and tapeworms
and round worms, i.e., nematodes.
225. 225
INTRODUCTION
• Humans are the primary hosts for the most of helminthic
infections.
• Most worms produce in human sexually by producing
eggs and larvae (The larva is a worm-like creature, which
emerges from an egg.)
• These pass out of body and infect the secondary host
• These invade humans via skin or GIT.
226. 226
Types (clinical)
1. Worms live in hosts alimentary canal. E.g
Tapeworm
2. Worms or larvae live in other tissues of host
body like muscles , viscera , menninges ,
lungs, subcutaneous tissues. E.g: Taenia
solium
228. Drugs for the treatment of
Nematodes
• Nematodes are elongated roundworms that
posses a complete digestion system including
both a mouth and an anus.
• They cause infection of intestine as well as the
blood and tissue.
229. 229
MEBENDAZOLE(Vermox)
• it is a synthetic benzimidazole
• it has wider spectrum
Mechanism of action:
It inhibits microtubule synthesis in nematodes that
irreversibly impairs glucose uptake. Intestinal parasites
are immobilized and die slowy.
It kills hook worm, pin worm , ascariasis and trichuris eggs.
230. 230
Pharmacokinetics:
• less than 10% of orally administered drug is absorbed
• Absorption increases with fatty meal.
• Absorbed drug is 90 % protein bound
• It is converted to inactive metabolites rapidly in liver.
• It has half life of 2-6 hours
• It is primarily excreted in urine.
231. 231
Thiabendazole
• it is benzimidazole
• it is chelating agent and form stable complexes with
metals including iron, but does not bind with calcium.
• it is rapidly absorbed
• it has half life of 1.2 hrs
• It is completely metabolized in liver and 90% is
excreted in urine
• it can also get absorbed through skin
232. 232
Thiabendazole
Mechanism of action: similar to other benzimidazoles (It inhibits
microtubule synthesis ). It is ovicidal for some parasites.
Adverse reactions and contraindications:
• It is more toxic than other benzamidazoles
• GI disturbances
• Pruritus ,headache, drowsiness , psychoneurotic symptoms
(anxiety, depression, or other feelings of unhappiness ).
• Irreversible live failure.
• Fatal Steven –Johnson syndrome(inflammation of skin)
• Not used in children below 15 kg weight. pregnancy, hepatic and
renal diseases.
233. 233
PYRANTEL PAMOATE
• It is a broad specturm anthelmintic.
Pharmacokinetics:
• It is poorly absorbed orally ,
• Half of the drug is excreted unchanged in the feces.
Mechanism of action:
• It is a depolrazing neuromuscular blocking agent that causes
release of acetylcholine and inhibition of cholinestrase leads
to paralizes of worms. The paralyzed worm is then expelled
from the host intestinal tract.
234. 234
Pyrental Pamoate
Adverse Effects:
• Infrequent mild transient GI disturbance
• drowsiness , headache ,insomnia.
• Rash ,fever
Contraindications:
• Should not be used in liver diseases.
• Pregnancy
• and child under 2 years of age
235. Drugs for the treatment of
Trematodes
• The trematodes (flukes) are leaf shaped
flatworms that are generally characterized by
the tissues they infect.
• For example, they maybe categorized as liver,
lung, intestinal or blood flukes.
236. Praziquantel
• Agent of choice for treatment of all
forms of schistosomiasis and other
trematode infections.
• Rapidly absorbed after oral
administration and distributes into CSF.
• High level occur in bile
• Drug is excreted through urine and
bile.
• Contraindicated for occular
cysticercosis because of destruction of
the organism in the eye may damage
the organ.
237. Mechanism of action
• The mode of action is not exactly known at present,
but experimental evidence indicates praziquantel
increases the permeability of the membranes of
schistosome cells towards calcium ions.
• The drug thereby induces contraction of the parasites,
resulting in paralysis in the contracted state.
• The dying parasites are dislodged from their site of
action in the host organism and may enter systemic
circulation or may be destroyed by host immune
reaction (phagocytosis).
238. Drugs for the treatment of Cestodes
• The cestodes or true tapeworms typically have
a flat, segmented body and attach to the hosts
intestine.
• Like trematodes the tapeworms lack a mouth
and a digestive tract throughout their life
cycle.
239. 239
NICLOSAMIDE
• It is a useful drug for treatment of tape worm (cestodes)
• Mechanism of action:
• Adult worm is rapidly killed by inhibition of
mitochondiral oxidative phosphorylation of adenosine
diphosphate or stimulation of ATPase activity.
Pharmacokinetics:
• It is poorly absorbed from gut
• Neither drug nor its metabolites are found in blood or
urine
240. 240
Niclosamide
Adverse effects:
• Mild ,infrequent and transitory GI disturbance
• Alcohol consumption should be avoided
• not indicated in children under 2 years of age.
241. 241
ALBENDAZOLE
• It is a broad spectrum
• It is a drug of choice (primary therapeutic
application) for treatment of hydatid disease or
cystecercosis, it is also used for the treatment
of intestinal nematodes like ascariasis
,tricurasis and strongyloidiasis , pinworm,
hookworm
242. 242
Albendazole
Mechanism of action: It inhibits microtubule
synthesis in nematodes(intestinal round worms)
that irreversibly impairs glucose uptake, intestinal
parasites are immobilized and die slowly.
• It is larvicidal in hydatid ,cysticercosis ,
ascariasis and hook worm infection.
• Also ovicidal in ascariasis ,
ancyclostomiasis(hookworm) , tricurasis
243. 243
Pharmacokinetics (Albendazole)
• It is benzimidazole
• it is adminstered orally , and absorbed
erratically (unpredictable) , absorption can be
increased with fatty meal
• It is metabolized in the liver rapidly to active
metabolite albendazole sulphoxide
244. 244
Pharmacokinetics (Albendazole)
• It has a plasma half life of 8-12 hours
• Sulphoxide is mostly protein bound ,
distributes well to tissues and enters bile,
csf, hydated cyst
• Metabolites are excreted in urine
245. 245
Clinical uses (albendazole)
• used on empty stomach when used against
intraluminal parasites but with fatty meal when
against tissue parasites.
• In ascariasis ,tricurasis ,hookworm, pin worm
infection : children under 2 years 400 mg orally as
a single dose repeated for 2-3 days in heavy
ascariasis ,repeated after 2-3 wks for pin worm
2. Hydated diseases:
drug of choice ,400 mg twice with meals for 1
month or longer.
246. 246
Albendazole
3. Neurocysticercosis: It is controversial as it has not
proved superior to corticosteroid alone.
It is used along with cotricosteroid to decrease the
inflammation caused by dying organism and it also
reduces the duration of course i.e. 400 mg twice
daily for 21 days
4. Other infections: Drug of choice in cutaneous and
visceral larvea migrans , intestinal cappillariasis and
others
247. 247
Albendazole
Adverse effects:
• In short term: use no significant adverse effects.
• In long term use : as used in hydatid cyst and
cysticercosis, abdominal distress, headache ,fever ,
fatigue, alopecia , increased liver enzymes , pancytopenia.
Blood counts and LFT should be followed.
• Not given during pregnancy and in hypersensitive
people.
255. 255
1. Alimentary canal(intestinal tape worms)
B) TAPE WORMS (CESTODES)
• Taenia saginata(Beaf) ,
• Taenia solium(Pork),Hymenolepis
nana(Dwarf) ,diphylobothrium latum(Fish)
• Humans become infected by eating raw or
under cooked meat containing larvae of
infected cattle or pig which has encysted in the
animal muscle tissue.
256. 256
Cestodes
• In some conditions this larvae may develop
in humans resulting cysticercosis (i.e. larvae
gets encysted in the muscle and viscera or
more seriously in the brain or eye.)
• both adult worm and larvae can be present
in the same host.
259. 259
2. TISSUE WORMS
A.TREMATODES(Schisotomes)OR FLUKES(leaf like)
• Schistosoma haematobium
• Schistosoma Japonicum
• Schistosoma mansoni
(These cause SCHISTASOMIASIS) also called
(BILHARZIA) means disease of blood vessels.
Adult worms of both sex live and mate in veins or
venules of the gut wall or the bladder, eggs pass into the
bladder or gut and produce inflammation of these organs ,
resulting in haematuria or loss of blood in feces.
260. • Paragonimus westermani (lung fluke)
disease is caused by eating raw crab or fish ,
larvae move from intestine to blood and settle
in lungs
• Clonorchis sinensis(liver fluke)
disease is caused by eating raw fish and worm
settle in the biliary tract
260
261. 261
Tissue worms
• B. TISSUE ROUND WORMS
Trichnella spiralis.
Dracunulus medinensis (guinea worm)larva
migrate from intestine to tissue of leg or foot and
protrude out by making ulcer
266. Introduction
• Protozoal infections are common among
people in underdeveloped tropical and
subtropical countries, where sanitary
conditions, hygienic practices and control of
vectors for transmission are inadequate.
• Most antiprotozoal agents have not proved to
be safe for pregnant patients.
268. Protozoal infections
1. Difficult to be treated than bacterial infections.
2. Protozoal cells (Eukaryotes) have metabolic processes closer
to human host than prokaryotic bacterial pathogens.
3. Many of antiprotozoal drugs cause toxic effects on the host.
4. Cells with high metabolic processes in the host are
susceptible.
5. Examples: bone marrow stem, renal tubular cells, intestinal
& neuronal cells.
6. Antiprotozoal are not safe during pregnancy.
271. Amebiasis
Amebiasis is a protozoal infection of the
intestinal tract that occurs due to ingestion of
foods or water contaminated with Entameba
Histolytica cysts
272. LIFE CYCLE
Entamoeba histolytica exists in two forms:
1. Cysts (infective):
• can survive outside the human body.
• transform to trophozoites.
2. Trophozoites (non-infective; invasive):
• Can reproduce
• They may feed on intestinal bacteria or
invade and ulcerate wall of large intestine,
and may migrate to liver or other tissues.
• transform to cysts which are excreted in
feces.
273. Life Cycle
1. Cysts ingestion.
2. Formation of trophozoites
3. Penetration of intestinal wall
4. Multiplication of trophozoites within colon
wall.
5. Systemic invasion.
6. Cyst formation in rectum and excretion in
feces.
276. LUMEN AMOEBICIDES
• Acts on the parasites in the lumen of the bowl.
• used for treatment of asymptomatic
amebiasis.
Include
• Diloxanide Furoate
• Iodoquinol
Antibiotics
- Paromomycin
- Tetracyclines
- Erythromycin
277. acts on the intestinal wall and liver (or any other
extra-intestinal tissue).
Used for treatment of systemic form of the
disease (intestinal wall infection or liver
abscesses).
Emetine
Dehydroemetine
Chloroquine (liver only)
Tissue Amoebicides (systemic)
278. Mixed amoebicides
Effective against both luminal and systemic
forms of the disease. Although luminal
concentration is too low for single drug –
treatment.
• Metronidazol
• Tinidazole
280. METRONIDAZOLE
• Mixed amoebicide.
• Drug of choice for intestinal &
extraintestinal amoebiasis.
• Acts on trophozoites.
• Has no effect on cysts.
• Nitro group of metronidazole is reduced by
protozoan leading to cytotoxic reduced product
that binds to DNA and proteins resulting into
parasite death.
281. Pharmacokinetics
• Given orally or IV.
• Absorption is rapid and complete.
▪ Due to rapid absorption from GIT, not reliably
effective against luminal parasites.
• Wide distribution to all tissues and body fluids
(CSF, saliva, milk).
• Plasma protein binding is low ( < 20%).
• Plasma half life is 8 h
282. Pharmacokinetics
• Metabolized in liver by mixed function oxidase
followed by glucouroidation.
• Excreted in urine as unchanged drug plus
metabolites.
• Clearance is decreased in liver impairment.
Tinidazole has longer duration, simpler dosing
regimen, less toxicity, than metronidazole, but is
equally active.
284. Adverse effects
2. CNS: Neurotoxicological effect
– Insomnia, dizziness
– peripheral neuropathy, paresthesia ( burning or
prickling sensation)
– Encphalopathy (disease of the brain that alters
brain function or structure), convulsion ( IV
infusion, rare).
3. Dysuria (Painful urination), dark urine.
4. Neutropenia
5. Disulfiram-like effect if taken with alcohol.
nausea, vomiting, flushing, dizziness, throbbing
headache, chest and abdominal discomfort
285. Disulfiram like -effect
When metronidazole is given with alcohol
abdominal distress, nausea, vomiting, flushing, or
headache, tachycardia, hyperventilation
alcohol aldehyde
dehydrogenase dehydrogenase
Ethanol Acetaldehyde Acetate
286. EMETINE AND DEHYDROEMETINE
Chemistry:
Emetine hydrochloride is a plant alkaloid
(organic nitrogen-containing bases) derived
from ipeca.
Dehydroemetine is a synthetic analogue
Pharmacokinetics:
Erratic oral absorption.
Given preferably subcutaneously but could be
given by IM.
Plasma half life is 5 days.
287. EMETINE
• Concentrated in Liver, Lungs, Spleen, Kidney,
Cardiac muscle and Intestinal wall.
• Metabolized & Excreted slowly via kidney so
it has a cumulative effect.
• Trace amounts could be detected in urine 1-2
month after last dose.
• Should not be used for more than 10 days
(usually 3-5 days).
288. Mechanism
• Act on tissue trophozoites causing irreversible
block of protein synthesis.
289. Adverse Effects
• Dehydroemetine is less toxic than emetine
• pain at site of injection, abcesses ( painful
collection of pus).
GIT: nausea, vomiting, diarrhoea.
Neuromuscular weakness
Serious toxicities: cardiotoxicity
- cardiac arrhythmias,
- Hypotension
- heart failure
290. Chloroquine
• Antiamebic drug
• Antimalarial drug
• Used in combination with metronidazole
and luminal amebicide for amebic liver
diseases.
291. Luminal amoebicides
• acts on the luminal parasites like Entamoeba
histolytica (Amebae) Balantidium coli (Ciliates).
• used for treatment of asymptomatic
amebiasis.
Include
Diloxanide Furoate
• Iodoquinol
• Antibiotics
- Paromomycin
- Tetracyclines
- Erythromycin
292. Diloxanide furoate
Chemistry
• Ester of diloxanide + furoic acid .
Pharmacokinetics
• Given orally.
• Split in the intestine, most of diloxanide is
absorbed, conjugated to form a glucoronide
which is excreted in urine (90%).
• The unabsorbed diloxanide is the amoebicidal
agent (10%).
294. Therapeutic Uses
• Drug of choice for asymptomatic intestinal
infection.
• For eradication of infection given along with
all forms of amebiasis.
• Dose: 500 mg three times/day for 10 days.
295. Adverse Effects
• Flatulence
• Nausea, vomiting, abdominal cramps.
• No serious adverse effects
Contraindications:
- Pregnancy
- Children (less than 2 years).
296. Paromomycin Sulphate
• Aminoglycoside, not absorbed.
• Effective against luminal forms of ameba
Mechanism of action
• Direct amebicidal action (causes leakage by its
action on cell membrane of parasite).
• Indirect killing of bacterial flora essential for
proliferation of pathogenic amoebae.
297. Kinetics
• Orally
• Not significantly absorbed from the GIT
• Small amount absorbed is excreted unchanged
in urine (may accumulate with renal
insufficiency).
299. Tetracyclines
• Very weak direct amoebicidal action.
• Mainly act indirectly on bacterial flora.
• Used in severe cases of amoebic dysentery not
responding to metronidazole combined with
dehydroemetine.
300. HALOGENATED HYDROXYQUINOLINES
• Iodoquinol
Mechanism of action
• Unknown
• Effective against organisms in GIT only Not
intestinal wall or liver.
Pharmacokinetics
• Absorption is poor, excreted in feces.
• 10% enter circulation, excreted as glucouronide in
urine.
• Half life is 11-14 h
301. Uses
• lumen amoebicide.
• For eradication of infection given along with
tissue amoebicide (metronidazole).
302. Adverse Effects
• Peripheral neuropathy including optic
neuritis
• GIT: Nausea, vomiting, diarrhoea.
• Enlargement of the thyroid gland.
• Agranulocytosis (low number of
granulocytes).
• Iodine sensitivity.
• interference with thyroid function tests
(increase protein-bound serum iodine,
decrease in measured 131I uptake).
303. Contraindications
• Optic neuropathy
• Thyroid disease
• Sensitivity to iodine
• Severe liver disease
• Severe kidney disease
• discontinued if it produces persistent
diarrhea or signs of iodine toxicity
(dermatitis, urticaria, pruritus, fever)
305. • Anti Malarials: The word "malaria" actually derives from
the Italian for "bad air"-- the mal'aria associated with marshes
and swamps.
• Malaria is a febrile (related to fever) disease caused by a
single-celled parasite known as a sporozoan (able to form
spore-like cells, from which they get their name) and
transmitted by a female mosquitoes of the genus Anopheles.
• This sporozoan belongs to the genus Plasmodium, and the five
species that infect humans are:
• Plasmodium falciparum
• Plasmodium malariae
• Plasmodium ovale
• Plasmodium vivax
• Plasmodium knowlesi
306. • Signs and symptoms:
• High grade fever
• Headache
• Spleenomegaly
• Sweating and chills
• Muscles aches
• Nausea, vomitting and diarrhoea
• Anemia etc
307. • Life cycle plasmodium:
• Antimalarials: Agents used for treatment and prophylaxis of malaria.
308. PARASITE LIFE CYCLE
An anopheline mosquito inoculates plasmodium sporozoites to
initiate human infection. Circulating sporozoites rapidly invade
liver cells, and exoerythrocytic stage tissue schizonts mature in
the liver. Merozoites are subsequently released from the liver
and invade erythrocytes.
Only erythrocytic parasites cause clinical illness. Sexual stage
gametocytes also develop in erythrocytes before being taken up
by mosquitoes, where they develop into infective sporozoites.
310. DRUG CLASSIFICATION
Tissue schizonticides: eliminate developing or dormant
liver forms;
Blood schizonticides : act on erythrocytic parasites;
Gametocides : kill sexual stages and prevent
transmission to mosquitoes.
Radical cure: eliminate both hepatic and erythrocytic
stages. Not available.
312. PRIMAQUINE
Hepatic stages of all human malaria parasites.
Chemoprophylaxis against all malarial species.
It is the only available agent active against the dormant stages of
p vivax and p ovale.
Gametocidal against the 4 human malaria species.
Acts against erythrocytic stage parasites, but this activity is too
weak to play an important role.
MOA: is unknown.
313. MECHANISM OF ACTION
Mechanism is not completely understood.
Metabolites of primaquine are believed to act as
oxidant that are responsible for schizonticidal actions
as well as for the hemolysis.
314. ADVERSE EFFECTS
Generally well tolerated.
• GI disturbance, Headache
•Leukopenia, Agranulocytosis,
•Cardiac Arrhythmias, Hemolysis
It is never given parenterally because it may induce marked hypotension.
It should be avoided in pregnancy because the fetus is relatively
G6PD(glucose-6-phosphate dehydrogenase)-deficient and thus at risk of
hemolysis.
316. CHLOROQUINE
For treatment and chemoprophylaxis since the 1940s,(drug
resistance).
Oral use
Antimalarial Action:
Highly effective blood schizonticide.
Moderately effective against gametocytes of P vivax, P
ovale, and P malariae but not against those of P falciparum.
Not active against liver stage parasites.
317. MECHANISM OF ACTION
Acts by :
concentrating in parasite food vacuoles, preventing
the biocrystallization of the hemoglobin breakdown
product, heme, into hemozoin, and thus eliciting
parasite toxicity due to the buildup of free heme.
318. CLINICAL USES
Drug of choice in the treatment of nonfalciparum and sensitive
falciparum malaria.
It is still used to treat falciparum : safety, low cost, antipyretic
properties, and partial activity.
Does not eliminate dormant liver forms of P vivax and P ovale, and for
that reason Primaquine must be added for the radical cure of these
species.
319. ADVERSE EFFECTS
• Usually very well tolerated
• Pruritus, GI disturbance, headache, malaise, blurring of vision, and
urticaria
• Rare : hemolysis in G6PD-deficient persons, impaired hearing,
agranulocytosis, alopecia, bleaching of hair, hypotension,
• Large IM injections or rapid IV infusions : severe
hypotension and respiratory and cardiac arrest.
320. Mefloquine
Used in chloroquine-resistant strains of P falciparum and other species.
Is chemically related to quinine.
Can only be given orally because severe local irritation occurs with parenteral use.
Has strong blood schizonticidal activity against P falciparum and P vivax,
it is not active against hepatic stages or gametocytes.
MOA:
The mechanism of action of mefloquine is not completely understood. Some studies
suggest that mefloquine specifically targets the 80S ribosome of the Plasmodium
falciparum, inhibiting protein synthesis and causing subsequent schizonticidal
effects..
321. QUININE & QUINIDINE
• First-line therapies for falciparum
malaria.
• Oral administration.
• Higher plasma levels and half-life in infected persons
than in healthy controls, but toxicity is not increased,
apparently because of increased protein binding.
• MOA: is unknown,
322. Antimalarial action
Is rapid-acting, highly effective blood schizonticide
against the 4 species of human malaria parasites.
Gametocidal against p vivax and p ovale but not p
falciparum
Not active against liver stage parasites.
323. ARTEMISININ & ITS DERIVATIVES
Artemisinin: used orally.
Analogs are:
Artesunate (water-soluble; oral, IM, IV and rectally),
Artemether (lipid-soluble; oral, IM, and rectally),
Dihydroartemisinin (water-soluble; oral).
They are very rapidly acting blood schizonticides against all human
malaria parasites, no effect on hepatic stages.
324. MOA
The parasite when it infects a RBC, it consumes Hb within its digestive
vacuole, liberating free heme, The iron in heme interacts with
Artemisinin producing reactive oxygen radicals which damage the
parasite leading to its death
Or inhibition of a parasite calcium transporter.
Artemisinin-based combination therapy is now the standard for
treatment of uncomplicated falciparum malaria in nearly all areas
endemic for falciparum malaria.
GI disturbance, dizziness, neutropenia, anemia,
hemolysis, elevated liver enzymes, allergic reactions.
325. INHIBITORS OF FOLATE SYNTHESIS
Pyrimethamine ,Proguanil ( Blood Schizonticide and Sporozoite)
•Used in combination regimens, in the treatment and prevention of malaria.
•Slowly but adequately absorbed from the GIT.
Fansidar, a fixed combination of the sulfonamide sulfadoxine and
pyrimethamine .
Act slowly against erythrocytic forms of susceptible strains of all
human malaria species.
Proguanil also has some activity against hepatic forms.
Neither drug is adequately gametocidal or effective against the
persistent liver stages of p vivax or p ovale.
326. MECHANISM OF ACTION
Selectively inhibit plasmodial dihydrofolate reductase, a key enzyme
in the pathway for synthesis of folate.
Sulfonamides and sulfones inhibit another enzyme in the folate
pathway, dihydropteroate synthase.
: GI Symptoms, Skin Rashes, Itching.
Proguanil: Mouth Ulcers, Alopecia .
Proguanil , Fansidar are considered safe in pregnancy